![]() |
Volumn 54, Issue 2, 2003, Pages 99-101
|
Women's health
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
ANTITHROMBOCYTIC AGENT;
ESTROGEN;
ACUTE HEART INFARCTION;
BIRTH RATE;
BREAST CANCER;
CANCER;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DEMENTIA;
DEPRESSION;
DEVELOPED COUNTRY;
DIABETES MELLITUS;
DRUG COST;
EDITORIAL;
ELDERLY CARE;
EMPLOYMENT;
ENVIRONMENTAL FACTOR;
EXERCISE;
FEMALE;
GYNECOLOGY;
HEALTH;
HEALTH PROMOTION;
HEART DISEASE;
HORMONE SUBSTITUTION;
HUMAN;
LIFESPAN;
LIFESTYLE;
MARRIAGE;
MENOPAUSE;
MENTAL DISEASE;
MENTAL HEALTH;
MORBIDITY;
MORTALITY;
OBSTETRICS;
OSTEOPOROSIS;
PREVENTIVE MEDICINE;
PSYCHOSOCIAL ENVIRONMENT;
QUALITY ADJUSTED LIFE YEAR;
QUALITY OF LIFE;
REPRODUCTIVE HEALTH;
SEX DIFFERENCE;
SIDE EFFECT;
SOCIAL STATUS;
SOCIOECONOMICS;
STROKE;
THROMBOEMBOLISM;
WORK ENVIRONMENT;
BREAST NEOPLASMS;
CARDIOVASCULAR DISEASES;
DIABETES MELLITUS;
FEMALE;
HUMANS;
PSYCHOLOGY;
RESEARCH;
WOMEN'S HEALTH;
|
EID: 0037291967
PISSN: 00223999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0022-3999(02)00549-4 Document Type: Editorial |
Times cited : (3)
|
References (5)
|